Cantor Fitzgerald Maintains Overweight on Zai Lab, Lowers Price Target to $37
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Cantor Fitzgerald analyst Li Watsek maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $55 to $37.
Cantor Fitzgerald analyst Li Watsek maintains Zai Lab (NASDAQ:ZLAB) with a Overweight and lowers the price target from $55 to $37.